319 related articles for article (PubMed ID: 30200724)
1. [Effect of traditional Chinese medicine in inhibiting obesity and inflammatory diseases by regulating gut microbiota].
Sang TT; Guo CJ; Guo DD; Wang XY
Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(16):3235-3242. PubMed ID: 30200724
[TBL] [Abstract][Full Text] [Related]
2. Dietary compounds and traditional Chinese medicine ameliorate type 2 diabetes by modulating gut microbiota.
Nie Q; Chen H; Hu J; Fan S; Nie S
Crit Rev Food Sci Nutr; 2019; 59(6):848-863. PubMed ID: 30569745
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine - a case study of diabetes and nonalcoholic fatty liver disease.
Bao Y; Han X; Liu D; Tan Z; Deng Y
Front Immunol; 2022; 13():1072376. PubMed ID: 36618372
[TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese Medicine and Intestinal Microbiota: A Complementary and Integrative Health Approach to Ameliorate Obesity-Related Diseases.
Liang Y; Lin C; Huang S; Xu Y
Holist Nurs Pract; 2019; 33(5):259-265. PubMed ID: 30648978
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
[TBL] [Abstract][Full Text] [Related]
6. An overview of traditional Chinese medicine affecting gut microbiota in obesity.
Li D; Tang W; Wang Y; Gao Q; Zhang H; Zhang Y; Wang Y; Yang Y; Zhou Y; Zhang Y; Li H; Li S; Zhao H
Front Endocrinol (Lausanne); 2023; 14():1149751. PubMed ID: 36936157
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease.
Yang YJ; Ni YH
J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S55-S61. PubMed ID: 30509561
[TBL] [Abstract][Full Text] [Related]
8. Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis.
Zheng Y; Ding Q; Wei Y; Gou X; Tian J; Li M; Tong X
Phytomedicine; 2021 Jul; 88():153455. PubMed ID: 33478831
[TBL] [Abstract][Full Text] [Related]
9. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
Kirpich IA; Marsano LS; McClain CJ
Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
[TBL] [Abstract][Full Text] [Related]
10. Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).
Nobili V; Mosca A; Alterio T; Cardile S; Putignani L
Adv Exp Med Biol; 2019; 1125():85-100. PubMed ID: 30578461
[TBL] [Abstract][Full Text] [Related]
11. Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy.
Zhu LR; Li SS; Zheng WQ; Ni WJ; Cai M; Liu HP
Front Immunol; 2023; 14():1086078. PubMed ID: 36817459
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.
Ma J; Zhou Q; Li H
Nutrients; 2017 Oct; 9(10):. PubMed ID: 29035308
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Flora: A Pivotal Role in Investigation of Traditional Chinese Medicine.
Li X; Wu D; Niu J; Sun Y; Wang Q; Yang B; Kuang H
Am J Chin Med; 2021; 49(2):237-268. PubMed ID: 33622213
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota transplantation in metabolic syndrome: History, present and future.
de Groot PF; Frissen MN; de Clercq NC; Nieuwdorp M
Gut Microbes; 2017 May; 8(3):253-267. PubMed ID: 28609252
[TBL] [Abstract][Full Text] [Related]
15. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
16. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
[No Abstract] [Full Text] [Related]
17. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
18. Fecal microbiota transplantation for gastrointestinal disorders.
Malikowski T; Khanna S; Pardi DS
Curr Opin Gastroenterol; 2017 Jan; 33(1):8-13. PubMed ID: 28134687
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and type 2 diabetes mellitus.
Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanism of Polysaccharides Extracted from Chinese Medicine Targeting Gut Microbiota for Promoting Health.
Zhao WX; Wang T; Zhang YN; Chen Q; Wang Y; Xing YQ; Zheng J; Duan CC; Chen LJ; Zhao HJ; Wang SJ
Chin J Integr Med; 2024 Feb; 30(2):171-180. PubMed ID: 35583582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
